Plasma β-amyloid in Alzheimer’s disease and vascular disease

Implementation of amyloid biomarkers in clinical practice would be accelerated if such biomarkers could be measured in blood. We analyzed plasma levels of Aβ42 and Aβ40 in a cohort of 719 individuals (the Swedish BioFINDER study), including patients with subjective cognitive decline (SCD), mild cogn...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Janelidze, Shorena, Stomrud, Erik, Palmqvist, Sebastian, Zetterberg, Henrik, van Westen, Danielle, Jeromin, Andreas, Song, Linan, Hanlon, David, Tan Hehir, Cristina A., Baker, David, Blennow, Kaj, Hansson, Oskar
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4886210/
https://ncbi.nlm.nih.gov/pubmed/27241045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep26801
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars